• Sign In
  • Register
  • Glossary
  • Share/Bookmark
  • RSS
All About Bleeding

von Willebrand factor (VWF)

This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate country-specific website.

Learn More

Read how treatment improved a patient's life with von Willebrand Disease.

Factor Products

Coagulation therapy is the foundation of CSL Behring’s broad range of therapies.

Learn More

Indications

Virus-inactivated concentrates are the treatment of choice for patients unresponsive to desmopressin (DDVAP).25

Commercially available VWF concentrates have shown excellent or good hemostasis preoperatively. Efficacy has also been shown in acute spontaneous bleeding and surgical events.25

CSL Behring von Willebrand factor products include:

Registration status and indications for factor concentrates vary from country to country. Please contact your CSL Behring company representative and review the respective prescribing information before considering using a von Willebrand factor concentrate.














Last Updated: 7/22/2014 8:16 PM
  • E-mail
  • Print
  • Share